🇺🇸 FDA
Patent

US 11066667

Organic compositions to treat APOC3-related diseases

granted A61KA61K31/713

Quick answer

US patent 11066667 (Organic compositions to treat APOC3-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/713